✦ LIBER ✦

Quantification of abciximab-induced platelet inhibition is assay dependent: A comparative study in patients undergoing percutaneous coronary intervention

✍ Scribed by Mark I. Furman; Dean J. Kereiakes; Lori A. Krueger; Michele N. Mueller; Thomas M. Broderick; John F. Schneider; Wendy L. Howard; Marsha L. Fox; Marc R. Barnard; A.L. Frelinger III; Alan D. Michelson

Book ID: 117842987
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 125 KB
Volume: 145
Category: Article
ISSN: 1097-6744
DOI: 10.1067/mhj.2003.116

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A comparative study of light transmissio

A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban

✍ Daniel I. Simon; Christopher B. Liu; Peter Ganz; James M. Kirshenbaum; Robert N. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

The ultegra rapid platelet-function assa

The ultegra rapid platelet-function assay: Comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abciximab therapy

✍ Guy L. Wheeler; Gregory A. Braden; Steven R. Steinhubl; Dean J. Kereiakes; Kandi 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 486 KB

Time course, magnitude, and consistency

Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention

✍ Dean J Kereiakes; Thomas M Broderick; Eli M Roth; David Whang; Thomas Shimshak; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 454 KB

A Trial of Early Inhibition of Platelet

A Trial of Early Inhibition of Platelet Aggregation in Patients with Acute Coronary Syndrome (ACS) Undergoing Percutaneous Intervention (PCI): High Dose Tirofiban Bolus and Infusion Compared to Standard Dose Abciximab

✍ C.C.S. Lim; B. Chou; L. Roberts; V. Pandeli; A. Teh; Y.M. Cheong; C. Goods; M. R 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Optimal platelet inhibition in patients

Optimal platelet inhibition in patients undergoing PCI: Data from the Multicenter Registry of High-Risk Percutaneous Coronary Intervention and Adequate Platelet Inhibition (MR PCI) study

✍ H.M. Mardikar; M.S. Hiremath; David J. Moliterno; Rony Mathew; Rangolee Arora; D 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Effects of intracoronary compared to int

Effects of intracoronary compared to intravenous abciximab administration in patients undergoing transradial percutaneous coronary intervention: A sub-analysis of the EASY trial

✍ Olivier F. Bertrand; Josep Rodés-Cabau; Éric Larose; Can Manh Nguyen; Jean-Pierr 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 258 KB